drugset / Trial / NCT01577693

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects

NCT01577693

Phase 1 Completed 35 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the bioavailability of 0.5mg dutasteride novel formulation compared to the currently marketed 0.5mg dutasteride soft gel capsule in fasted healthy male subjects.

Timeline

Start
2011-05-12
Primary completion
2011-08-31
Completion
2011-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule 0.5 mg Oral